Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Designing Successful Cell And Gene Therapy Trials
Designing cell and gene therapy trials requires specialized strategies to navigate unique complexities, ensuring successful and compliant development.
Why Team Integration Makes Or Breaks Marketing Applications
True team integration transcends basic collaboration, requiring the dismantling of barriers between sponsors and vendors, eliminating departmental silos, and cultivating mutual accountability.
How State-Of-The-Art Clinical Trial Mobile Vision Clinics Work
Are you seeking a non-traditional option to complete the eye exams necessary for your ocular clinical trials? A mobile clinic may be the solution you're looking for.
Practical Approaches To Clinical Trial Diversity
Gain insights on FDA diversity action plans, and the important role that data points play in ensuring inclusion of underrepresented populations.

Ensuring A Diverse Patient Population In Clinical Trials
12/13/2024

In 2025, the FDA will require pharmaceutical companies to include diversity action plans (DAPs) for Phase II and pivotal studies.
Vendor Selection Bias: Why Structured Decisions Often Fail
12/22/2025

Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
How Humans And AI Collaborate To Improve Quality, Speed, And Agility In Study Build
6/22/2026

Learn how combining human expertise with AI can improve speed, consistency, and oversight while identifying issues earlier and supporting higher-quality clinical trial execution.
From Chaos To Clarity: A Founder's View From 30 Years In Drug Development
7/16/2026

Same workflows, higher stakes. A 30-year drug development veteran reveals how outdated sample handling puts trial outcomes at risk and what sponsors can do about it.
Leading Recruitment With A Strong Alzheimer's Referral Pool
2/24/2026

A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.

Your Top Partner For Ophthalmic Drug Development

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
Patient Liaison: Per-Visit Participant Support

Dedicated Patient Liaison support helps coordinate participant travel, reimbursements, and visit logistics so sites stay focused and study requests keep moving forward.
Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle

Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
Ophthalmic Clinical Research Services

With over 40 clinical trials conducted in the area of ophthalmology, Altasciences combines depth of knowledge and expert capabilities to offer you a full range of early ophthalmic clinical development.
Biotech-Tailored Clinical Development

Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.